Veeraveni Baddireddi

Veeraveni Baddireddi

Active Director Managing Director DIN 07737735
DIN 07737735 First appointment Apr 2017 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Veeraveni Baddireddi

Data last updated:

Veeraveni Baddireddi is a Managing Director at Augment Therapeutics Private Limited (since 2017). The company operates in Pharma.

DIN 07737735
Primary Designation Managing Director
Industry Pharma
First Appointment 06 Apr 2017
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Augment Therapeutics Private Limited U74999TG2017PTC116352
Managing Director06 Apr 20172017Active

Board colleagues of Veeraveni Baddireddi

NameDINCompanyDesignation
Apparao Satyam07745124Augment Therapeutics Private LimitedWhole-Time Director

Directorship timeline

Open interactive timeline →
Augment Therapeutics Private Limited
Premium access

Shareholding and investment profile for Veeraveni Baddireddi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Veeraveni Baddireddi

Veeraveni Baddireddi currently holds 1 directorship: Augment Therapeutics Private Limited (Managing Director, since 06 Apr 2017).

Veeraveni Baddireddi was first appointed on 06 Apr 2017 as Managing Director at Augment Therapeutics Private Limited.

The current boards of Veeraveni Baddireddi's companies include Apparao Satyam (Augment Therapeutics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available